NCT03669653

Brief Summary

he purpose of this study is to determine the efficacy and safety of remote ischemic conditioning for acute ischemic stroke.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
912

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Jun 2025Sep 2026

First Submitted

Initial submission to the registry

August 27, 2018

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 13, 2018

Completed
6.8 years until next milestone

Study Start

First participant enrolled

June 17, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2026

Last Updated

October 2, 2024

Status Verified

February 1, 2024

Enrollment Period

1.3 years

First QC Date

August 27, 2018

Last Update Submit

October 1, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients with Modified Rankin Scale (mRS) Score 0-2

    The primary outcome measure of efficacy is the modified Rankin Scale (mRS) dichotomized to define good functional outcome as mRS 0-2 at 90 days.score, dichotomized to define good functional outcome as mRS 0-2 at 90 days.

    3 months

Secondary Outcomes (4)

  • NIHSS Score at end of 7th day of treatment

    7 days

  • mRS Score at end of 7th day of treatment

    7 days

  • Barthel Index at end of 7th day of treatment

    7 days

  • Changes of hematological indicators

    48h; 7days

Study Arms (2)

RIC+Standard medical treatment

ACTIVE COMPARATOR

Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflations of a blood pressure cuff to 200 mm Hg. RIC will be conducted twice daily for 7 days. Additionally,the patients will be treated with standard medical treatment according to Guidelines for diagnosis and treatment of acute ischemic stroke in China 2014

Procedure: Remote ischemic conditioning

Sham RIC+Standard medical treatment

PLACEBO COMPARATOR

Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflations of a blood pressure cuff to 60 mm Hg. RIC will be conducted twice daily for 7 days. Additionally,the patients will be treated with standard medical treatment according to Guidelines for diagnosis and treatment of acute ischemic stroke in China 2014

Procedure: Sham remote ischemic conditioning

Interventions

Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflations of a blood pressure cuff to 200 mm Hg. RIC will be conducted twice daily for 7 days.

RIC+Standard medical treatment

Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflations of a blood pressure cuff to 60 mm Hg. RIC will be conducted twice daily for 7 days.

Sham RIC+Standard medical treatment

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • )Age≥18 years, \< 80 years, regardless of sex;
  • )Patients with clinically definite diagnosis of acute ischemic stroke and able to commence RIC treatment within 12 hours of stroke onset
  • )Baseline NIHSS score\>5, and≤25 ;
  • )GCS score ≥8;
  • )Signed and dated informed consent is obtained

You may not qualify if:

  • \) Patients with suspected posterior circulation infarction;
  • \) Patients who undergo thrombolytic therapy or endovascular treatment;
  • \) mRS≥2 score before the onset of the disease;
  • \) Double upper limbs or lower limbs paralysis was found in this case;
  • )Active bleeding of organs within 6 months of admission or current, including cerebral hemorrhage, subarachnoid hemorrhage, gastrointestinal hemorrhage, fundus hemorrhage and so on;
  • \) Other intracranial lesions, such as cerebrovascular malformation cerebral venous diseases, tumor and other diseases involving the brain;
  • \) Treated blood pressure ≤90mmHg/60mmHg or≥180mmHg/100mmHg;
  • \) Severe organ dysfunction or failure;
  • \) Persons suffering from severe hematological diseases or severe coagulation disorder dysfunction;
  • \) Those who had a history of severe trauma or had major surgery within 6 months prior to admission;
  • \) The patients who had the contraindication of remote ischemic conditioning treatment, such as severe soft tissue injury, fracture or vascular injury in the upper limb;Acute or subacute venous thrombosis, arterial occlusive disease, subclavian steal syndrome, etc;
  • \) Pregnant or lactating women;
  • \) Previous remote ischemic conditioning therapy or similar treatment;
  • \) Patients with a life expectancy of less than 3 months or patients unable to complete the study for other reasons;
  • \) Severe hepatic and renal dysfunction
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Hospital of Jilin University

Changchun, Jilin, 130000, China

Location

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Zhen-Ni Guo, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Trial and Research Center for Stroke

Study Record Dates

First Submitted

August 27, 2018

First Posted

September 13, 2018

Study Start

June 17, 2025

Primary Completion (Estimated)

September 20, 2026

Study Completion (Estimated)

September 20, 2026

Last Updated

October 2, 2024

Record last verified: 2024-02

Locations